CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity (original) (raw)

References

  1. Walker JM, Hohmann AG, Martin WJ, Strangman NM, Huang SM, Tsou K . The neurobiology of cannabinoid analgesia. Life Sci 1999; 65: 665–673.
    Article CAS Google Scholar
  2. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O . Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 2002; 159: 379–387.
    Article CAS Google Scholar
  3. Terranova JP, Michaud JC, Le Fur G, Soubrié P . Inhibition of long-term potentiation in rat hippocampal slices anandamide and WIN55212-2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 1995; 352: 576–579.
    Article CAS Google Scholar
  4. Kirkham TC, Williams CM . Endogenous cannabinoids and appetite. Nutr Res Rev 2001; 14: 65–86.
    Article CAS Google Scholar
  5. Koch JE . 9-THC stimulates food intake in Lewis rats. Effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 2001; 68: 539–543.
    Article CAS Google Scholar
  6. Williams CM, Kirkham TC . Observational analysis of feeding induced by Δ9-THC and anandamide. Physiol Behav 2002; 76: 241–250.
    Article CAS Google Scholar
  7. Williams CM, Kirkham TC . Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 1999; 143: 315–317.
    Article CAS Google Scholar
  8. Kirkham TC, Williams CM, Fezza F, Di Marzo V . Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002; 136: 550–557.
    Article CAS Google Scholar
  9. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G . SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994; 350: 240–244.
    Article CAS Google Scholar
  10. Williams CM, Kirkham TC . Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 2002; 71: 341–348.
    Article Google Scholar
  11. Colombo G, Agabio R, Diaz G . Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci 1998; 63: 113–117.
    Article Google Scholar
  12. Rowland NE, Mukherjee M, Robertson K . Effects of the cannabinoid receptor antagonist SR141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 2001; 159: 111–116.
    Article CAS Google Scholar
  13. Arnone M, Jung M, Keane PE, Maffrand JP, Soubrié P . The CB1 cannabinoid receptor antagonist SR141716 reduces sucrose intake and fat diet preference in lean and obese rats. Int J Obes Relat Metab Disord 1999; 23 (Suppl 5): S63.
    Google Scholar
  14. Simiand J, Keane M, Keane PE, Soubrié P . SR141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 1998; 9: 179–181.
    CAS Google Scholar
  15. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubrié P . Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003; 284: R345–R353.
    Article Google Scholar
  16. Di Marzo V, Goparaju SK, Wang L, Liu J, Bátkai S, Járai Z, Fezza F, Miuras GI, Palmiter RD, Sugiura T, Kunos G . Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822–825.
    Article CAS Google Scholar
  17. Hildebrandt AL, Kelly-Sullivan DM, Black SC . Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 2003; 462 (1–3): 125–132.
    Article CAS Google Scholar
  18. Cota D, Giovanni M, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S, Tomessoni F, Cervino C, Nisoli E, Linthorst AG, Pasquali R, Lutz B, Stella GK, Pagotto U . The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003; 112: 423–431.
    Article CAS Google Scholar
  19. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ . Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci 2002; 99: 8384–8388.
    Article CAS Google Scholar
  20. Dickinson K, North TJ, Telford G, Smith S, Brammer R, Jones RB, Heal DJ . Determination of body composition in conscious adult female Wistar utilising total body electrical conductivity. Physiol Behav 2001; 74: 425–433.
    Article CAS Google Scholar
  21. Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA . Preferential effects of the cannabinoid CB1 receptor antagonist, SR141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 2003; 167: 103–111.
    Article CAS Google Scholar
  22. West DB, Boozer CN, Moody DL, Atkinson RL . Dietary obesity in nine inbred mouse strains. Am J Physiol Regul Integr Comp Physiol 1992; 262: R1025–R1032.
    Article CAS Google Scholar
  23. Kirkham TC, Williams CM . The cannabinoid receptor antagonist SR141716 fails to suppress sucrose sham feeding. J Psychopharmacol 1998; 12 (Suppl A): 37.
    Google Scholar
  24. Gallate JE, McGregor IS . The motivation for beer in rats: effects of ritanserin, naloxone and SR141716. Psychopharmacology 1999; 142: 302–308.
    Article CAS Google Scholar
  25. Gallate JE, Saharov T, Mallet PE, McGregor IS . Increase motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 1999; 370: 233–240.
    Article CAS Google Scholar
  26. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrié P . The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003; 63: 908–914.
    Article CAS Google Scholar
  27. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci 2001; 98: 2005–2010.
    Article CAS Google Scholar
  28. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E . Mice laking melanin-concentrating hormone are hypophagic and lean. Nature 1998; 396: 670–674.
    Article CAS Google Scholar
  29. Erickson JC, Clegg KE, Palmiter RD . Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415–418.
    Article CAS Google Scholar
  30. Hollopeter G, Erickson JC, Seeley RJ, Marsh DJ, Palmiter RD . Response of neuropeptide Y-deficient mice to feeding effectors. Regulat Pept 1998; 75–76: 383–389.
    Article Google Scholar
  31. Kim JY, Nolte LA, Hansen PA, Han DH, Ferguson K, Thompson PA, Holloszy JO . High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2057–R2065.
    Article CAS Google Scholar
  32. Lemonnier D, Suquet JP, Aubert R, De Gasquet P, Pequignot E . Metabolism of the mouse made obese by a high-fat diet. Diabetes Metab 1975; 1: 77–85.
    CAS Google Scholar
  33. Sindelka G, Skrha J, Prazny M, Haas T . Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action. Physiol Res 2002; 51: 85–91.
    CAS PubMed Google Scholar

Download references